Autophagy induction by silibinin positively contributes to its anti-metastatic capacity via AMPK/mTOR pathway in renal cell carcinoma.
Autophagy induction by silibinin positively contributes to its anti-metastatic capacity via AMPK/mTOR pathway in renal cell carcinoma.
复制标题
DOI:
10.3390/ijms16048415
复制
发表时间:
2015-04-15
影响因子:
5.6
通讯作者:
Zeng J
中科院分区:
文献类型:
--
作者:
Li F;Ma Z;Guan Z;Chen Y;Wu K;Guo P;Wang X;He D;Zeng J
Silibinin, a dietary cancer chemopreventive flavonoid from the seeds of milk thistle, has been reported to exhibit anti-metastatic effects on renal cell carcinoma (RCC), but the mechanism underlying this phenomenon is not fully understood. The present study aimed at examining the potential role of autophagy in regulating silibinin-induced anti-metastatic effects on RCC cells. Using RCC ACHN and 786-O cells as a model system in vitro, we found that silibinin treatment increased the expression of LC3-II, resulted in the formation of autophagolysosome vacuoles, and caused a punctate fluorescence pattern with the monomeric red fluorescence protein-enhanced green fluorescence protein-LC3 (mRFP-EGFP-LC3) protein, which all are markers for cellular autophagy. Autophagy flux was induced by silibinin in RCC cells, as determined by LC3 turnover assay. Mechanically, the adenosine 5'-monophosphate activated protein kinase (AMPK)/mammalian target of rapamycin (mTOR) pathway was identified as involved in regulation of silibinin-induced autophagy. Furthermore, autophagy induction was demonstrated to positively contribute to silibinin-induced anti-metastatic effects on RCC cells in vitro. Activation of autophagy enhanced silibinin-induced inhibition of migration and invasion of RCC cells, while inhibition of autophagy attenuated it. These findings thus provide new information about the potential link between autophagy and metastasis inhibition induced by silibinin, and the induction of autophagy may shed some light into future treatment strategies for metastatic RCC.
登录
查看更多内容
DOI:
10.1136/bmj.g4797
发表时间:
2014-11-10
期刊:
BMJ (Clinical research ed.)
影响因子:
--
作者:
Jonasch E;Gao J;Rathmell WK
通讯作者:
Rathmell WK
影响因子:
9.7
作者:
Li, Lei;Gao, Ye;Sun, Yi
通讯作者:
Sun, Yi
影响因子:
4.2
作者:
Liang, Liang;Li, Lei;He, Dalin
通讯作者:
He, Dalin
影响因子:
13.3
作者:
Raina, Komal;Agarwal, Chapla;Agarwal, Rajesh
通讯作者:
Agarwal, Rajesh
影响因子:
15.3
作者:
Bhatt, Jaimin R.;Finelli, Antonio
通讯作者:
Finelli, Antonio